U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 209

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr5:14758709
GRCh38:
Chr5:14758600
ANKHCraniometaphyseal dysplasia, autosomal dominantLikely pathogenic
(Oct 31, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr5:14769313
GRCh38:
Chr5:14769204
ANKHnot provided, Craniometaphyseal dysplasia, autosomal dominantBenign/Likely benign
(Apr 4, 2023)
criteria provided, multiple submitters, no conflicts
3.
GRCh37:
Chr5:14751366
GRCh38:
Chr5:14751257
ANKHCraniometaphyseal dysplasia, autosomal dominant, not providedBenign/Likely benign
(Oct 5, 2022)
criteria provided, multiple submitters, no conflicts
4.
GRCh37:
Chr5:14751399
GRCh38:
Chr5:14751290
ANKHCraniometaphyseal dysplasia, autosomal dominant, not providedBenign
(Jul 14, 2021)
criteria provided, multiple submitters, no conflicts
5.
GRCh37:
Chr5:14749226
GRCh38:
Chr5:14749117
ANKHnot provided, Craniometaphyseal dysplasia, autosomal dominantBenign/Likely benign
(Dec 5, 2021)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr5:14746064
GRCh38:
Chr5:14745955
ANKHA277VCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Uncertain significance
(Jul 10, 2020)
no assertion criteria provided
7.
GRCh37:
Chr5:14707763
GRCh38:
Chr5:14707654
ANKH, OTULINChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantBenign
(Jan 13, 2018)
criteria provided, single submitter
8.
GRCh37:
Chr5:14707752
GRCh38:
Chr5:14707643
ANKH, OTULINChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
9.
GRCh37:
Chr5:14706671
GRCh38:
Chr5:14706562
ANKH, OTULINChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
10.
GRCh37:
Chr5:14705547
GRCh38:
Chr5:14705438
ANKH, OTULINChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantBenign
(Jan 13, 2018)
criteria provided, single submitter
11.
GRCh37:
Chr5:14705419
GRCh38:
Chr5:14705310
OTULIN, ANKHChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
12.
GRCh37:
Chr5:14871808
GRCh38:
Chr5:14871699
ANKHChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantBenign
(Jan 13, 2018)
criteria provided, single submitter
13.
GRCh37:
Chr5:14711210
GRCh38:
Chr5:14711101
ANKH, OTULINChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
14.
GRCh37:
Chr5:14711159
GRCh38:
Chr5:14711050
ANKH, OTULINChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
15.
GRCh37:
Chr5:14711050
GRCh38:
Chr5:14710941
ANKH, OTULINChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
16.
GRCh37:
Chr5:14710487
GRCh38:
Chr5:14710378
ANKH, OTULINChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantBenign
(Jan 12, 2018)
criteria provided, single submitter
17.
GRCh37:
Chr5:14709412
GRCh38:
Chr5:14709303
ANKH, OTULINChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
18.
GRCh37:
Chr5:14708632
GRCh38:
Chr5:14708523
ANKH, OTULINCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
19.
GRCh37:
Chr5:14706529
GRCh38:
Chr5:14706420
ANKH, OTULINCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
20.
GRCh37:
Chr5:14706495
GRCh38:
Chr5:14706386
ANKH, OTULINCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
21.
GRCh37:
Chr5:14706324
GRCh38:
Chr5:14706215
ANKH, OTULINCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
22.
GRCh37:
Chr5:14705407
GRCh38:
Chr5:14705298
ANKH, OTULINCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
23.
GRCh37:
Chr5:14705080
GRCh38:
Chr5:14704971
ANKH, OTULINCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Benign
(Jan 12, 2018)
criteria provided, single submitter
24.
GRCh37:
Chr5:14705071
GRCh38:
Chr5:14704962
ANKH, OTULINCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
25.
GRCh37:
Chr5:14704938
GRCh38:
Chr5:14704829
ANKH, OTULINCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
26.
GRCh37:
Chr5:14769309
GRCh38:
Chr5:14769200
ANKHCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
27.
GRCh37:
Chr5:14713044
GRCh38:
Chr5:14712935
ANKH, LOC100130744, OTULINA435Vnot provided, Craniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2
Conflicting interpretations of pathogenicity
(Jun 27, 2022)
criteria provided, conflicting interpretations
28.
GRCh37:
Chr5:14710997
GRCh38:
Chr5:14710888
ANKH, OTULINChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
29.
GRCh37:
Chr5:14710473
GRCh38:
Chr5:14710364
ANKH, OTULINChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
30.
GRCh37:
Chr5:14709934
GRCh38:
Chr5:14709825
ANKH, OTULINCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
31.
GRCh37:
Chr5:14709883
GRCh38:
Chr5:14709774
OTULIN, ANKHChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
32.
GRCh37:
Chr5:14709855
GRCh38:
Chr5:14709746
ANKH, OTULINChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
33.
GRCh37:
Chr5:14709318
GRCh38:
Chr5:14709209
ANKH, OTULINCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Benign
(Jan 13, 2018)
criteria provided, single submitter
34.
GRCh37:
Chr5:14709289
GRCh38:
Chr5:14709180
ANKH, OTULINCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
35.
GRCh37:
Chr5:14708632
GRCh38:
Chr5:14708523
ANKH, OTULINCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
36.
GRCh37:
Chr5:14707744
GRCh38:
Chr5:14707635
ANKH, OTULINCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
37.
GRCh37:
Chr5:14707739
GRCh38:
Chr5:14707630
ANKH, OTULINCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
38.
GRCh37:
Chr5:14712991
GRCh38:
Chr5:14712882
ANKH, LOC100130744, OTULINR453WCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2, not provided
Conflicting interpretations of pathogenicity
(Apr 8, 2022)
criteria provided, conflicting interpretations
39.
GRCh37:
Chr5:14712974
GRCh38:
Chr5:14712865
OTULIN, ANKH, LOC100130744Craniometaphyseal dysplasia, autosomal dominant, not provided, Chondrocalcinosis 2
Benign/Likely benign
(Dec 5, 2021)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr5:14712970
GRCh38:
Chr5:14712861
ANKH, LOC100130744, OTULINCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2, not provided
Benign
(Aug 31, 2022)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr5:14710307
GRCh38:
Chr5:14710198
ANKH, OTULINCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
42.
GRCh37:
Chr5:14709836
GRCh38:
Chr5:14709727
ANKH, OTULINCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
43.
GRCh37:
Chr5:14709816
GRCh38:
Chr5:14709707
ANKH, OTULINCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
44.
GRCh37:
Chr5:14709660
GRCh38:
Chr5:14709551
ANKH, OTULINCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
45.
GRCh37:
Chr5:14708347
GRCh38:
Chr5:14708238
ANKH, OTULINCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
46.
GRCh37:
Chr5:14708173
GRCh38:
Chr5:14708064
ANKH, OTULINCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
47.
GRCh37:
Chr5:14708134
GRCh38:
Chr5:14708025
ANKH, OTULINCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
48.
GRCh37:
Chr5:14706244
GRCh38:
Chr5:14706135
ANKH, OTULINCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
49.
GRCh37:
Chr5:14705788
GRCh38:
Chr5:14705679
OTULIN, ANKHChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantBenign
(Jan 13, 2018)
criteria provided, single submitter
50.
GRCh37:
Chr5:14705727
GRCh38:
Chr5:14705618
ANKH, OTULINChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
51.
GRCh37:
Chr5:14705406
GRCh38:
Chr5:14705297
ANKH, OTULINChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
52.
GRCh37:
Chr5:14705400
GRCh38:
Chr5:14705291
ANKH, OTULINCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
53.
GRCh37:
Chr5:14705376
GRCh38:
Chr5:14705267
ANKH, OTULINCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
54.
GRCh37:
Chr5:14769241
GRCh38:
Chr5:14769132
ANKHCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
55.
GRCh37:
Chr5:14769115
GRCh38:
Chr5:14769006
ANKHnot provided, Craniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2
Benign/Likely benign
(Dec 5, 2021)
criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr5:14745997
GRCh38:
Chr5:14745888
ANKHChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
57.
GRCh37:
Chr5:14745965
GRCh38:
Chr5:14745856
ANKHnot provided, Chondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominant
Benign/Likely benign
(Aug 31, 2022)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr5:14709044
GRCh38:
Chr5:14708935
ANKH, OTULINChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantBenign
(Jan 12, 2018)
criteria provided, single submitter
59.
GRCh37:
Chr5:14708913
GRCh38:
Chr5:14708804
ANKH, OTULINChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
60.
GRCh37:
Chr5:14708082
GRCh38:
Chr5:14707973
ANKH, OTULINChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
61.
GRCh37:
Chr5:14707947
GRCh38:
Chr5:14707838
ANKH, OTULINChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantUncertain significance
(Apr 27, 2017)
criteria provided, single submitter
62.
GRCh37:
Chr5:14707797
GRCh38:
Chr5:14707688
ANKH, OTULINChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
63.
GRCh37:
Chr5:14707554
GRCh38:
Chr5:14707445
ANKH, OTULINnot provided, Craniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2
Uncertain significance
(Apr 1, 2022)
criteria provided, multiple submitters, no conflicts
64.
GRCh37:
Chr5:14706955
GRCh38:
Chr5:14706846
ANKH, OTULINChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantBenign
(Jan 13, 2018)
criteria provided, single submitter
65.
GRCh37:
Chr5:14706878
GRCh38:
Chr5:14706769
ANKH, OTULINCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Benign
(Jan 13, 2018)
criteria provided, single submitter
66.
GRCh37:
Chr5:14706696
GRCh38:
Chr5:14706587
ANKH, OTULINChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
67.
GRCh37:
Chr5:14705326
GRCh38:
Chr5:14705217
ANKH, OTULINChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
68.
GRCh37:
Chr5:14705300
GRCh38:
Chr5:14705191
ANKH, OTULINChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
69.
GRCh37:
Chr5:14751265
GRCh38:
Chr5:14751156
ANKHnot provided, Chondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominant
Conflicting interpretations of pathogenicity
(Oct 11, 2021)
criteria provided, conflicting interpretations
70.
GRCh37:
Chr5:14742010
GRCh38:
Chr5:14741901
ANKHV313MInborn genetic diseases, Craniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2
Uncertain significance
(Nov 10, 2022)
criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr5:14741947
GRCh38:
Chr5:14741838
ANKHL334Vnot provided, Craniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2
Conflicting interpretations of pathogenicity
(Sep 26, 2022)
criteria provided, conflicting interpretations
72.
GRCh37:
Chr5:14716935
GRCh38:
Chr5:14716826
ANKHV341Mnot provided, Chondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominant
Conflicting interpretations of pathogenicity
(Oct 27, 2022)
criteria provided, conflicting interpretations
73.
GRCh37:
Chr5:14711276
GRCh38:
Chr5:14711167
ANKH, OTULINChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
74.
GRCh37:
Chr5:14710606
GRCh38:
Chr5:14710497
ANKH, OTULINChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
75.
GRCh37:
Chr5:14710169
GRCh38:
Chr5:14710060
ANKH, OTULINChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
76.
GRCh37:
Chr5:14710114
GRCh38:
Chr5:14710005
ANKH, OTULINChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantBenign
(Jan 13, 2018)
criteria provided, single submitter
77.
GRCh37:
Chr5:14709553
GRCh38:
Chr5:14709444
ANKH, OTULINCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
78.
GRCh37:
Chr5:14709552
GRCh38:
Chr5:14709443
ANKH, OTULINCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
79.
GRCh37:
Chr5:14709534
GRCh38:
Chr5:14709425
ANKH, OTULINChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
80.
GRCh37:
Chr5:14741960
GRCh38:
Chr5:14741851
ANKHCraniometaphyseal dysplasia, autosomal dominant, not providedBenign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
81.
GRCh37:
Chr5:14758652
GRCh38:
Chr5:14758543
ANKHCraniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2, not provided
Benign/Likely benign
(Oct 2, 2022)
criteria provided, multiple submitters, no conflicts
82.
GRCh37:
Chr5:14713088
GRCh38:
Chr5:14712979
OTULIN, ANKH, LOC100130744Craniometaphyseal dysplasia, autosomal dominant, not providedBenign/Likely benign
(Aug 23, 2022)
criteria provided, multiple submitters, no conflicts
83.
GRCh37:
Chr5:14871643
GRCh38:
Chr5:14871534
ANKH, LOC129993725Craniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
84.
GRCh37:
Chr5:14871621-14871628
GRCh38:
Chr5:14871512-14871519
ANKH, LOC129993725Craniometaphyseal dysplasia, autosomal dominant, Craniometadiaphyseal dysplasia wormian bone type, not provided,
Chondrocalcinosis
Benign
(Dec 5, 2021)
criteria provided, multiple submitters, no conflicts
85.
GRCh37:
Chr5:14871560
GRCh38:
Chr5:14871451
ANKHnot provided, Chondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominant
Benign
(Sep 27, 2022)
criteria provided, multiple submitters, no conflicts
86.
GRCh37:
Chr5:14871518
GRCh38:
Chr5:14871409
ANKHnot provided, Chondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominant
Likely benign
(Sep 4, 2021)
criteria provided, multiple submitters, no conflicts
87.
GRCh37:
Chr5:14769139
GRCh38:
Chr5:14769030
ANKHnot provided, Chondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominant
Benign
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
88.
GRCh37:
Chr5:14769109
GRCh38:
Chr5:14769000
ANKHnot provided, Chondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominant
Benign/Likely benign
(Oct 29, 2022)
criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr5:14769103
GRCh38:
Chr5:14768994
ANKHnot provided, Chondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominant
Benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr5:14769075
GRCh38:
Chr5:14768966
ANKHnot provided, Chondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominant
Benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
91.
GRCh37:
Chr5:14769072
GRCh38:
Chr5:14768963
ANKHChondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominantUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
92.
GRCh37:
Chr5:14758720
GRCh38:
Chr5:14758611
ANKHnot provided, Chondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominant
Benign/Likely benign
(Sep 8, 2022)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr5:14758616
GRCh38:
Chr5:14758507
ANKHnot provided, Craniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
94.
GRCh37:
Chr5:14758576
GRCh38:
Chr5:14758467
ANKHnot provided, Craniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2
Benign/Likely benign
(Oct 23, 2022)
criteria provided, multiple submitters, no conflicts
95.
GRCh37:
Chr5:14751305
GRCh38:
Chr5:14751196
ANKHR187QCraniometaphyseal dysplasia, autosomal dominant, not specified, not provided,
Chondrocalcinosis 2
Benign/Likely benign
(Oct 1, 2023)
criteria provided, multiple submitters, no conflicts
96.
GRCh37:
Chr5:14751280
GRCh38:
Chr5:14751171
ANKHnot provided, Craniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2
Conflicting interpretations of pathogenicity
(Oct 24, 2022)
criteria provided, conflicting interpretations
97.
GRCh37:
Chr5:14751184
GRCh38:
Chr5:14751075
ANKHnot provided, Chondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominant
Benign/Likely benign
(Sep 28, 2022)
criteria provided, multiple submitters, no conflicts
98.
GRCh37:
Chr5:14749429
GRCh38:
Chr5:14749320
ANKHnot provided, Craniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2,
Chondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominant
Benign
(Oct 22, 2022)
criteria provided, multiple submitters, no conflicts
99.
GRCh37:
Chr5:14741984
GRCh38:
Chr5:14741875
ANKHnot provided, Craniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2
Benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
100.
GRCh37:
Chr5:14741921
GRCh38:
Chr5:14741812
ANKHnot provided, Craniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2
Benign
(Oct 30, 2022)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination